弱势人群中脂肪肝的无创纤维化筛查:糖尿病与肥胖对FIB-4评分准确性的影响
研究评估FIB-4指数在糖尿病和肥胖情况下筛查晚期肝纤维化的准确性,对比肝活检。363例脂肪肝患者中,FIB-4总体c-statistic为0.79,糖尿病者0.68低于无糖尿病者0.85(P=0.003);准确性随体重变化但无统计学差异(P=0.24)。结论提示FIB-4在筛查晚期肝纤维化方面存在局限性,尤其在糖尿病患者中。
要点
- FIB-4筛查晚期肝纤维化总体c-statistic为0.79。
- 糖尿病者FIB-4的c-statistic为0.68,低于无糖尿病者的0.85(P=0.003)。
- FIB-4准确性随体重变化但无统计学差异(P=0.24)。
核心结论
- 研究结果凸显FIB-4在筛查晚期肝纤维化方面的局限性,尤其在糖尿病患者中。
研究设计与样本
- 在2009年8月至2020年2月期间,于旧金山安全网医疗系统接受治疗的363例脂肪肝患者中,评估FIB-4对比肝活检诊断晚期肝纤维化的准确性。
主要发现
- 363例脂肪肝患者中,中位年龄51岁,46%为男性,59%为西班牙裔,68%为肥胖,33%有糖尿病,31%组织学诊断为晚期肝纤维化。
- FIB-4总体c-statistic为0.79。
- 糖尿病患者的c-statistic为0.68,低于无糖尿病患者的0.85(P=0.003)。
- FIB-4准确性按体重分组:正常体重0.65、超重0.85、肥胖0.75,但无统计学差异(P=0.24)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Fatty liver disease (FLD) is prevalent in diabetes, and both disproportionately affect vulnerable populations. The FIB-4 index is recommended to screen for advanced liver fibrosis. Limited data have suggested that diabetes may impact FIB-4. RESEARCH DESIGN AND METHODS: We evaluated FIB-4 accuracy for advanced fibrosis compared with liver biopsy in the presence of diabetes and obesity. RESULTS: Among 363 FLD patients receiving care in San Francisco's safety net health care system from August 2009 to February 2020, characteristics were as follows: median age 51 years, 46% male, 59% Hispanic, 68% obese, 33% with diabetes, and 31% with advanced fibrosis on histology. Overall, the c-statistic for FIB-4 was 0.79, but was worse in patients with diabetes, 0.68, than without, 0.85 (P = 0.003). Accuracy also varied by weight, at 0.65, 0.85, and 0.75 for normal weight, overweight, and obese, respectively, although not significantly (P = 0.24). CONCLUSIONS: The findings highlight limitations of FIB-4 in screening for advanced liver fibrosis, particularly in individuals with diabetes.
引用
- Kim RG, Deng J, Reaso JN, et al. Noninvasive Fibrosis Screening in Fatty Liver Disease Among Vulnerable Populations: Impact of Diabetes and Obesity on FIB-4 Score Accuracy. Diabetes Care. 2022. PMID: 35947698. doi:10.2337/dc22-0556
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。